Ibotta CEO logs 10b5-1 option exercise, share sale
Ibotta, Inc. director, CEO and President Bryan Leach reported a pre-planned mix of option exercises and stock sales in Class A Common Stock on July 6, 2026, executed under a Rule 10b5-1 trading plan established on March 5, 2026.
Rhea-AI Filing Summary
Ibotta, Inc. director, CEO and President Bryan Leach reported a pre-planned mix of option exercises and stock sales in Class A Common Stock on July 6, 2026, executed under a Rule 10b5-1 trading plan established on March 5, 2026.
He exercised 9,326 Employee Stock Options at an exercise price of $3.99 per share and sold a net 9,402 shares of Class A Common Stock in multiple open-market transactions at weighted average prices disclosed in the filing. After these trades, he directly holds 866,484 Class A shares.
Entities associated with his spouse, acting as trustee for the Elysian and Orion 2024 GST Trusts, converted small blocks of 38 Class B shares each into the same number of Class A shares and sold corresponding amounts. Separate Class B Common Stock positions remain outstanding and are convertible into Class A on a 1-for-1 basis at no cost.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 9,326 | $0.00 | $0.00 |
| Conversion | Class B Common Stock | 38 | $0.00 | $0.00 |
| Conversion | Class B Common Stock | 38 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 9,326 | $3.99 | $37K |
| Sale | Class A Common Stock | 5,711 | $32.6699 | $187K |
| Sale | Class A Common Stock | 2,723 | $33.4019 | $91K |
| Sale | Class A Common Stock | 844 | $34.774 | $29K |
| Sale | Class A Common Stock | 48 | $35.2425 | $2K |
| Conversion | Class A Common Stock | 38 | $0.00 | $0.00 |
| Sale | Class A Common Stock | 38 | $35.0692 | $1K |
| Conversion | Class A Common Stock | 38 | $0.00 | $0.00 |
| Sale | Class A Common Stock | 38 | $35.0692 | $1K |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
Footnotes (15)
- F1. The transactions reflected on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on March 5, 2026.
- F2. Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.11 to $33.09 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.14 to $34.14 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.15 to $35.045 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.23 to $35.28 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F7. The Elysian 2024 GST Trust u/a/d/ March 20, 2024, converted 38 shares of Class B Common Stock into a like number of shares of Class A Common Stock.
- F8. By Spouse as Trustee for the Elysian 2024 GST Trust u/a/d March 20, 2024.
- F9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.28 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F10. The Orion 2024 GST Trust u/a/d/ March 20, 2024, converted 38 shares of Class B Common Stock into a like number of shares of Class A Common Stock.
- F11. By Spouse as Trustee for the Orion 2024 GST Trust u/a/d March 20, 2024.
- F12. All of the shares subject to the option are fully vested and exercisable as of the date hereof.
- F13. Shares of Class B Common Stock are convertible into shares of Class A Common Stock on a 1-for-1 basis at no cost, at any time, at the election of the holder.
- F14. By Spouse as Trustee for the Orion 2021 Legacy Trust u/a/d May 11, 2021.
- F15. By Spouse as Trustee for the Elysian 2021 Legacy Trust u/a/d May 11, 2021.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
restricted stock units ("RSUs") financial
weighted average price financial
GST Trust financial
Employee Stock Option (right to buy) financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Ibotta (IBTA) CEO Bryan Leach report?
Were Bryan Leach’s Ibotta (IBTA) stock sales pre-planned under Rule 10b5-1?
What happened with Ibotta (IBTA) Class B and GST Trust holdings in this Form 4?
Did Bryan Leach exercise Ibotta (IBTA) stock options in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.